BI 1356 BS - Tablet
Sponsors
Boehringer Ingelheim
Conditions
Healthy
Phase 1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1356 BS Administered to Healthy Male Subjects
CompletedNCT02173665
Start: 2004-10-31Updated: 2014-07-08
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male Volunteers
CompletedNCT02183298
Start: 2006-05-31Updated: 2014-07-08